San Antonio Breast Cancer Symposium 2023
Symptom Management and Patient Empowerment in Routine Breast Cancer Care: The Deployment of Medical Remote Monitoring in 24 Hospitals in Europe.
Dec 4, 2025
2 minutes
Authors
Maria Alice Franzoi 1, Arlindo R. Ferreira [2,3], Juliette Fanton d’Anton 2, Joana Ribeiro 1, Thomas Grellety 4, Eliane Ithurbide-Dachary 4, Laura Polastro 5, Laurence Caravella 5, Joseph Rodriguez 6, Nathanaelle Leprevier 6, Stephane Remy 7, Belen d’Ythurbide 7, Elsa Blanchard 8, Raoudha Bourghzala 9, Jessica Grosjean 10, Jessica Selz 11, Romain Rivoirard 12, Ines Vaz Luis 1.
Affiliation
1. Gustave Roussy, Villejuif ; 2. Resilience, Paris ; 3. Católica Medical School, Universidade Católica Portuguesa, Lisbonne, Portugal ; 4. Centre Hospitalier de la Côte Basque, Bayonne ; 5. Institut Jules Bordet, Bruxelles, Belgique ; 6. Centre Hospitalier de Valenciennes ; 7. Clinique Belharra, Bayonne ; 8. Institut de Cancérologie et Radiothérapie Brétilien, Rennes, Saint-Malo ; 9. Hôpital Privé Arras Les Bonnettes ; 10. Centre de cancérologie Les Dentellières, Valenciennes ; 11. Institut de Cancérologie de Seine-et-Marne, Jossigny ; 12. Hôpital Privé de la Loire, Saint-Étienne.
Introduction
Medical remote monitoring based on ePROs (electronic Patient-Reported Outcomes) has demonstrated clinical and organizational benefits through Phase III randomized controlled clinical trials[1-4]. These benefits include:
- Symptom control,
- Quality of life,
- Reduction in the number of hospitalizations,
- Prolongation of overall survival.
Consequently, in 2022, ESMO published its recommendations regarding medical remote monitoring for routine clinical practice during anti-cancer treatments[5].
Resilience has developed an oncology medical remote monitoring solution (Class IIa medical device) that enables patients to answer a weekly questionnaire (PRO-CTCAE) regarding their common symptoms. Severe symptoms trigger an alert for the healthcare team. Personalized advice and educational resources are also provided to patients via the mobile application.
This study presents the deployment of the Resilience solution in routine clinical care for breast cancer patients in 28 facilities in Europe.
Poster presented at the 2023 SABCS (San Antonio Breast Cancer Symposium).
Sources
1. Mir O, Ferrua M, Fourcade A, et al. Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial. Nat Med.2022;28(6):1224-1231.
2. Basch E, Schrag D, Henson S, et al. Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial. JAMA. 2022;327(24):2413-2422.
3. Basch E, Deal AM, Kris MG, et al. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. J Clin Oncol. 2019 Feb20;37(6):528.
4. Basch E, Deal AM, Dueck AC, et al. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. JAMA.2017;318(2):197-198.
5. Di Maio M, Basch E, Denis F, et al. The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. Ann Oncol. 2022;33(9):878-892. doi:10.1016/j.annonc.2022.04.007.
